Anti-TLR7 Reference Antibody (U.Tokyo patent anti-TLR7) | Ubiquitin Ligase-ubiquitin-ligase.com

Product Name :
Anti-TLR7 Reference Antibody (U.Tokyo patent anti-TLR7)

synonym :
null,

productDescription :
Anti-TLR7 Reference Antibody (U.Tokyo patent anti-TLR7)(CHA569) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

molecularWeight :
145 kDa

endotoxin :
<0.001 EU/ug

purity :
>95%

formulation :
100 mM Pro-Ac 20mM Arg pH 5.0

storage :
-80°C for 2 years under sterile conditions； -20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles.

reactivity :
Human, Mouse, Cynomolgus [US10370451]

concentration :
1 mg/ml

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT1 Antibody (YA667)
GLP-1R Antibody
CD19 Antibody (YA807): CD19 Antibody (YA807) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD19 (3G7). It can be used for ICC/IF,FC assays with tag free, in the background of Human.

Author: Ubiquitin Ligase- ubiquitin-ligase

Related Posts